v3.24.0.1
Stock Option and Grant Plan (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-based Compensation Expense

Stock-based compensation expense recorded as research and development and general and administrative expenses in the consolidated statements of operations and other comprehensive loss is as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Research and development

 

$

57,812

 

 

$

52,004

 

 

$

26,644

 

General and administrative

 

 

40,835

 

 

 

32,317

 

 

 

16,926

 

Total stock-based compensation expense

 

$

98,647

 

 

$

84,321

 

 

$

43,570

 

 

Schedule of Assumptions Used in Black-Scholes Option-Pricing Model for Stock Options Granted

The assumptions used in the Black-Scholes option-pricing model for stock options granted were:

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Expected volatility

 

76.3-78.8%

 

 

74.8-77.3%

 

 

71.4-76.7%

 

Weighted-average risk-free interest rate

 

 

3.73

%

 

 

2.27

%

 

 

1.11

%

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

 

 

0.00

%

Expected term (in years)

 

 

6.03

 

 

 

6.08

 

 

 

6.12

 

Summary of Option Activity Under Equity Award Plans

The following table provides a summary of option activity under the Company’s equity award plans:

 

 

Number
of options

 

 

Weighted
average
exercise
price

 

 

Weighted
average
remaining
contractual
life (years)

 

 

Aggregate
intrinsic
value (1)
(in thousands)

 

Outstanding at December 31, 2022

 

 

7,548,392

 

 

$

41.77

 

 

 

7.5

 

 

$

110,990

 

Granted

 

 

2,356,838

 

 

 

39.62

 

 

 

 

 

 

 

Exercised

 

 

(797,709

)

 

 

7.69

 

 

 

 

 

 

 

Forfeitures

 

 

(831,488

)

 

 

60.18

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

8,276,033

 

 

 

42.59

 

 

 

7.2

 

 

 

51,653

 

Exercisable as of December 31, 2023

 

 

4,818,116

 

 

$

37.81

 

 

 

6.3

 

 

$

45,895

 

 

(1)
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money as of December 31, 2023 and 2022.
Summary of Restricted Stock Activity

The following summarizes the Company’s restricted stock activity:

 

 

Shares

 

 

Weighted-
average grant
date fair
value

 

Unvested as of December 31, 2022

 

 

1,692,819

 

 

$

65.49

 

Issued

 

 

2,050,025

 

 

 

28.69

 

Vested

 

 

(469,531

)

 

 

67.77

 

Forfeited

 

 

(346,161

)

 

 

52.49

 

Unvested as of December 31, 2023

 

 

2,927,152

 

 

$

40.89